Reexploration for hemorrhage following coronary artery bypass grafting: Incidence and risk factors

Archives of Surgery

Volumn 133, Issue 4, 1998, Pages 442-447

  Dacey, Lawrence J ^a,g   Munoz, John J ^a   Baribeau, Yvon R ^f   Johnson, Edward R ^c   Lahey, Stephen J ^b   Leavitt, Bruce J ^d   Quinn, Reed D ^e   Nugent, William C ^a   Birkmeyer, John D ^a   O'Connor, Gerald T ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c EASTERN MAINE MEDICAL CENTER   (United States)

^d FLETCHER ALLEN HEALTH CARE   (United States)

^e MAINE MEDICAL CENTER   (United States)

^f CATHOLIC MEDICAL CENTER   (United States)

^g Section of Cardiothoracic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; FIBRINOLYTIC AGENT;

ADULT; AGE; AGED; AORTA BALLOON; ARTICLE; BODY SURFACE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; RISK FACTOR;

EID: 15644382459     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.133.4.442     Document Type: Article

References (16)

1. Unsworth-White MJ, Herriot A, Valencia O, et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg. 1995;59:664-667.
2. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg. 1996;111:1037-1046.
3. Kaiser GC, Naunheim KS, Fiore AC, et al. Reoperation in the intensive care unit. Ann Thorac Surg. 1990;49:903-908.
4. Janssens M, Hartstein G, David J-L. Reduction in requirements for allogenic blood products: pharmacologic methods. Ann Thorac Surg. 1996;62:1944-1950.
5. O'Connor GT, Plume SK, Olmstead EM, et al. A regional prospective study of inhospital mortality associated with coronary artery bypass grafting. JAMA. 1991; 266:803-809.
6. O'Connor GT, Plume SK, Olmstead EM, et al. Multivariate prediction of inhospital mortality associated with coronary bypass surgery. Circulation. 1992; 85:2110-2118.
7. Pierpont GL, Kruse M, Ewald S, Weir EK. Practical problems in assessing risk for coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1985;89:673-682.
8. The Principal Investigators of CASS and Their Associates. The National Heart, Lung, and Blood Institute Coronary Artery Study (CASS). Circulation. 1981;63 (suppl):1-81.
9. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons; 1989.
10. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic curve. Diagn Radiol. 1982;143:29-36.
11. Despotis GJ, Filos KS, Zoys TN, Hogue CW Jr, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg. 1996;82:13-21.
12. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood. 1990;76:1680-1697.
13. Tuman KJ, McCarthy RJ, O'Connor CJ, McCarthy WE, Ivankovich AD. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg. 1996;83:1178-1184.
14. Hardy JF, Belisle S. Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency. Can J Anesth. 1994;41:1104-1112.
15. Dacey LJ, Schults WC, Johnson ER, et al. Effects of preoperative aspirin use on bleeding, transfusion, reexploration and in-hospital mortality in coronary artery bypass grafting patients. Circulation. 1995;92(suppl):1-644.
16. Davis R, Wnittington R. Aprotinin. a review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs. 1995; 49:954-983.